Detalles de la búsqueda
1.
Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma.
BMC Health Serv Res
; 22(1): 470, 2022 Apr 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35397521
2.
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.
N Engl J Med
; 378(8): 731-739, 2018 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29466156
3.
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer.
Br J Cancer
; 121(3): 211-217, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31231122
4.
Quantification of Anaplastic Lymphoma Kinase Protein Expression in Non-Small Cell Lung Cancer Tissues from Patients Treated with Crizotinib.
Clin Chem
; 62(1): 252-61, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26585927
5.
Adagrasib Treatment After Sotorasib-Related Hepatotoxicity in Patients With KRASG12C-Mutated Non-Small Cell Lung Cancer: A Case Series and Literature Review.
JCO Precis Oncol
; 8: e2300644, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38579193
6.
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers.
Nat Cancer
; 2024 Mar 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38528112
7.
Influence of TP53 Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in STK11-Mutant Non-Small-Cell Lung Cancer.
JCO Precis Oncol
; 8: e2300371, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38330261
8.
Activating point mutations in the MET kinase domain represent a unique molecular subset of lung cancer and other malignancies targetable with MET inhibitors.
Cancer Discov
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38564707
9.
Overview of various techniques/platforms with critical evaluation of each.
Curr Treat Options Oncol
; 14(4): 623-33, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24243164
10.
Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing.
JTO Clin Res Rep
; 3(9): 100381, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36082279
11.
Multi-hallmark long noncoding RNA maps reveal non-small cell lung cancer vulnerabilities.
Cell Genom
; 2(9): 100171, 2022 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36778670
12.
MET alterations and their impact on the future of non-small cell lung cancer (NSCLC) targeted therapies.
Expert Opin Ther Targets
; 25(4): 249-268, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33945380
13.
Immune-Related Adverse Events (irAE) in Cancer Immune Checkpoint Inhibitors (ICI) and Survival Outcomes Correlation: To Rechallenge or Not?
Cancers (Basel)
; 13(5)2021 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33673446
14.
A Prospective Trial Evaluating the Safety and Systemic Response From the Concurrent Use of Radiation Therapy with Checkpoint Inhibitor Immunotherapy in Metastatic Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 22(4): 268-273, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33608212
15.
Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.
Theranostics
; 11(14): 7092-7109, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34093873
16.
Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC).
Lung Cancer
; 160: 92-98, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34482103
17.
Quantifying EGFR alterations in the lung cancer genome with nanofluidic digital PCR arrays.
Clin Chem
; 56(4): 623-32, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20207772
18.
Patterns of disease progression to checkpoint inhibitor immunotherapy in patients with stage IV non-small cell lung cancer.
J Med Imaging Radiat Oncol
; 64(6): 866-872, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32881332
19.
Y Chromosome LncRNA Are Involved in Radiation Response of Male Non-Small Cell Lung Cancer Cells.
Cancer Res
; 80(19): 4046-4057, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32616503
20.
Expression and mutational analysis of MET in human solid cancers.
Genes Chromosomes Cancer
; 47(12): 1025-37, 2008 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-18709663